Shah Nimish P

CIK 000169808211 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001698082

Recent Transactions

21 trades

Purchase
Apogee Therapeutics, Inc.$APGE
Pre-Funded Warrants (Right to Buy)
2025-10-10$41.00/sh+365,853→ 365,853 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-06-17+14,461→ 14,461 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2024-06-05+10,370→ 10,370 total
Purchase
Apogee Therapeutics, Inc.$APGE
Common Stock
2023-07-13$17.00/sh+1,750,000→ 1,750,000 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2023-07-13+47,758→ 47,758 total
Purchase
Instil Bio, Inc.$TIL
Common Stock
2021-03-23$20.00/sh+19,620→ 19,620 total
Conversion
Instil Bio, Inc.$TIL
Series C Preferred Stock
2021-03-23−400,597→ 0 total
Conversion
Instil Bio, Inc.$TIL
Common Stock
2021-03-23+5,100,866→ 5,100,866 total
Conversion
Instil Bio, Inc.$TIL
Common Stock
2021-03-23+43,033→ 553,063 total
Purchase
Instil Bio, Inc.$TIL
Common Stock
2021-03-23$20.00/sh+10,470→ 563,533 total
Purchase
Instil Bio, Inc.$TIL
Common Stock
2021-03-23$20.00/sh+104,640→ 5,635,937 total
Purchase
Instil Bio, Inc.$TIL
Common Stock
2021-03-23$20.00/sh+116,880→ 597,596 total
Conversion
Instil Bio, Inc.$TIL
Common Stock
2021-03-23+430,431→ 5,531,297 total
Conversion
Instil Bio, Inc.$TIL
Series C Preferred Stock
2021-03-23−358,693→ 0 total
Purchase
Instil Bio, Inc.$TIL
Common Stock
2021-03-23$20.00/sh+48,390→ 48,390 total
Conversion
Instil Bio, Inc.$TIL
Series B Preferred Stock
2021-03-23−425,025→ 0 total
Conversion
Instil Bio, Inc.$TIL
Series C Preferred Stock
2021-03-23−35,861→ 0 total
Conversion
Instil Bio, Inc.$TIL
Common Stock
2021-03-23+510,030→ 510,030 total
Conversion
Instil Bio, Inc.$TIL
Series B Preferred Stock
2021-03-23−4,250,722→ 0 total
Conversion
Instil Bio, Inc.$TIL
Common Stock
2021-03-23+480,716→ 480,716 total
Award
Instil Bio, Inc.$TIL
Stock Option (right to buy)
2021-03-18+52,000→ 52,000 total

Companies

Recent Filings

Address

C/O VENROCK 7 BRYANT PARK, 23RD FLOOR

NEW YORK, NY, 10018

View on SEC.gov